These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 16707905

  • 1. Adolescents with childhood-onset GHD: how do we get them to peak bone mass?
    Shalet S.
    Horm Res; 2006; 65 Suppl 2():17-22. PubMed ID: 16707905
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
    Kuzma M, Payer J.
    Cas Lek Cesk; 2010; 149(5):211-6. PubMed ID: 20629339
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A, Murray RD, Shalet SM.
    Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
    [Abstract] [Full Text] [Related]

  • 6. Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: the impact on bone mass.
    Saggese G, Baroncelli GI, Vanacore T, Fiore L, Ruggieri S, Federico G.
    J Endocrinol Invest; 2004 Jun; 27(6):596-602. PubMed ID: 15717661
    [Abstract] [Full Text] [Related]

  • 7. Stepping into adulthood: the transition period.
    Shalet S.
    Horm Res; 2004 Jun; 62 Suppl 4():15-22. PubMed ID: 15591762
    [Abstract] [Full Text] [Related]

  • 8. Effect of GH treatment on bone mass in children with GH deficiency.
    Baroncelli GI, Saggese G.
    J Endocrinol Invest; 2005 Jun; 28(10 Suppl):23-7. PubMed ID: 16550718
    [Abstract] [Full Text] [Related]

  • 9. Influence of growth hormone on accretion of bone mass.
    Monson JP, Drake WM, Carroll PV, Weaver JU, Rodriguez-Arnao J, Savage MO.
    Horm Res; 2002 Jun; 58 Suppl 1():52-6. PubMed ID: 12373015
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Skeletal consequences of discontinuation of growth hormone at final height.
    Drake WM, Carroll PV, Savage MO, Monson JP.
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1351-4. PubMed ID: 12510990
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
    Boot AM, van der Sluis IM, Krenning EP, de Muinck Keizer-Schrama SM.
    Horm Res; 2009 Dec; 71(6):364-71. PubMed ID: 19506395
    [Abstract] [Full Text] [Related]

  • 14. Confirming the diagnosis of growth hormone deficiency (GHD) and transitioning the care of patients with childhood-onset GHD.
    Hintz RL.
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():631-5. PubMed ID: 12795365
    [Abstract] [Full Text] [Related]

  • 15. Indications for GH replacement in adolescents and young adults.
    Monson JP.
    J Endocrinol Invest; 2005 May; 28(5 Suppl):52-5. PubMed ID: 16114277
    [Abstract] [Full Text] [Related]

  • 16. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 17. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M.
    J Pediatr Endocrinol Metab; 2001 Nov; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone deficiency: strategies and indications to continue growth hormone therapy in transition from adolescence to adult life.
    Leong GM, Johannsson G.
    Horm Res; 2003 Nov; 60(Suppl 1):78-85. PubMed ID: 12955023
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [Abstract] [Full Text] [Related]

  • 20. Changes in bone mineral density after discontinuation and early reinstitution of growth hormone (GH) in patients with childhood-onset GH deficiency.
    Benbassat CA, Wasserman M, Laron Z.
    Growth Horm IGF Res; 1999 Oct; 9(5):290-5. PubMed ID: 10543936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.